In this interview, Martha Gulati MD MS FACC FAHA FASPC FESC and Alison L. Bailey MD, FACC, discuss the Top Takeaways from 2022: Preventive Cardiology.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In this interview, Dipti Itchhaporia MD, FACC and Alison L. Bailey MD FACC discuss the Top Takeaways from 2022 in Interventional Cardiology.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In this interview, Christopher M. Kramer MD, FACC and Alison L. Bailey, MD FACC discuss the Top Takeaways from 2022 in cardiovascular imaging.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In this interview, Clyde W. Yancy MD, MSc, MACC, FAHA, MACP and Alison L. Bailey MD FACC, discuss the Top Takeaways from 2022: Heart Failure. Dr. Yancy discusses trials including DELIVER, TRANSFORM-HF, DCP, BRIGhtn, and the ACC/AHA/HFSA Guidelines.

Earlier detection of people at risk of HF would enable cardioprotection to be initiated earlier and damage avoided. Current imaging tools (eg. ejection fraction) are not sensitive enough to identify early disease. While GLS has been shown to predict outcomes, this study shows that its use improves the predictive power of the current definition of stage B HF.

In this interview, Professor Tom Marwick  MBBS, PhD, MPH, FAHMS and John Gorcsan III MD, FACC discuss improving characterization of Stage A and B HF by adding strain.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In an effort to limit unnecessary testing and increase diagnostic yield, current major guideline recommendations recommend a risk-based strategy with deferred testing in low-risk patients, catheterization in high risk patients, and selective noninvasive testing for those at intermediate risk. To date, no randomized trial has explored the clinical efficacy and safety of any such strategy.

In this interview, Pamela S Douglas MD, MACC and Anthony N. DeMaria MD, MACC discuss Real World Implications of 2021 AHA/ACC Chest Pain Guidelines: Modeling of Deferred Testing Recommendations in the PROMISE Trial.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Thiazides are recommended first line agents for the treatment of hypertension.  They have been demonstrated to lower cardiovascular disease.  Which thiazide to choose has been a long-standing issue.

In this interview, Areef Ishani MD, MS and W. Douglas Weaver MD, MACC discuss AHA Late-Breaker: DCP – Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Cardiovascular Events in Patients with Hypertension.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Ultrasound can make it easier for cardiologists to do procedures including angioplasty or stenting when femoral artery is used.

In this interview, Sanjit Jolly MD, MSc and Matt Cavender MD MPH, FACC, with Sun Moon Kim MD FSCAI, FACC, discuss Routine Ultrasound for Vascular Access.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In this interview, Martin Halle MD and Steven E. Nissen MD, MACC discuss a recent piece in JACC: Exercise for Primary and Secondary Prevention of Cardiovascular Disease.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Any person with a smartphone can screen him- or herself for treatment-relevant atrial fibrillation - the world's most important arrhythmia. This could have huge impact on the prevention of stroke.

In this interview, Axel Bauer MD and Thomas F. Deering MD, FACC, with Sun Moon Kim MD, FSCAI, FACC, discuss ESC Late-Breaker: eBRAVE-AF: Smartphone-based AF screening.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL